Sabiedrība ar ierobežotu atbildību "Siguldas Nami"

Key FactsEnterprise Register · 16/02/2021

Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 20/01/2010
SEPA code: LV40ZZZ40103269441
Address: Siguldas nov., Sigulda, Vizbuļu iela 9
Region: 100015380
Equity capital: €2,845
NACE code: 21.2021.20 Manufacture of pharmaceutical preparations
Industry sector: CC › 21 › 21.2 › 21.20
Historical names: 1

StatusEnterprise Register · 16/02/2021

No issues detected

InsolvencyNone

LiquidationNone

VID suspensionsNone

SanctionsNone

Securing measuresNone

ReorganizationNone

Key Financials (2024)data for 2024

Revenue

€0

Net income

-€50

Total assets

€133,044

Equity capital

-€4,809

Employees

Profit margin

—

Current Ratio

17.98

ROA

-0.0%

Financial History

Insufficient data

ShareholdersEnterprise Register · 16/02/2021

JUR.Baltic Biomax, Sabiedrība ar ierobežotu atbildību

2,845

Beneficial Owners

Gatis DeksnisLV

Officials

Executive Board

Deksnis Gatis

Board Member

Power of AttorneyEnterprise Register · 16/02/2021

No prokūra data

Timeline

14/09/2021

Name changed from Sabiedrība ar ierobežotu atbildību "EUROPHA"

Sabiedrība ar ierobežotu atbildību "EUROPHA"

16/02/2021

BOARD_MEMBER, EXECUTIVE_BOARD appointed: Deksnis Gatis

Deksnis Gatis

16/02/2021

UBO declared: Gatis Deksnis

Gatis Deksnis

02/03/2015

Capital: Apmaksātais pamatkapitāls 2845 EUR

2845 EUR

16/02/2015

SIA shareholder: Baltic Biomax, Sabiedrība ar ierobežotu atbildību (2845 shares)

Baltic Biomax, Sabiedrība ar ierobežotu atbildību (2845 shares)

27/01/2010

Founding registered

20/01/2010

Company registered

10/01/2010

Founding decision signed

Key FactsEnterprise Register · 16/02/2021

Legal form: Sabiedrība ar ierobežotu atbildību
Registration date: 20/01/2010
SEPA code: LV40ZZZ40103269441
Address: Siguldas nov., Sigulda, Vizbuļu iela 9
Region: 100015380
Equity capital: €2,845
NACE code: 21.2021.20 Manufacture of pharmaceutical preparations
Industry sector: CC › 21 › 21.2 › 21.20
Historical names: 1

StatusEnterprise Register · 16/02/2021

No issues detected

InsolvencyNone

LiquidationNone

VID suspensionsNone

SanctionsNone

Securing measuresNone

ReorganizationNone

Key Financials (2024)data for 2024

Revenue

€0

Net income

-€50

Total assets

€133,044

Equity capital

-€4,809

Employees

Profit margin

—

Current Ratio

17.98

ROA

-0.0%

Financial History

Insufficient data

ShareholdersEnterprise Register · 16/02/2021

JUR.Baltic Biomax, Sabiedrība ar ierobežotu atbildību

2,845

Beneficial Owners

Gatis DeksnisLV

Officials

Executive Board

Deksnis Gatis

Board Member

Power of AttorneyEnterprise Register · 16/02/2021

No prokūra data

Timeline

14/09/2021

Name changed from Sabiedrība ar ierobežotu atbildību "EUROPHA"

Sabiedrība ar ierobežotu atbildību "EUROPHA"

16/02/2021

BOARD_MEMBER, EXECUTIVE_BOARD appointed: Deksnis Gatis

Deksnis Gatis

16/02/2021

UBO declared: Gatis Deksnis

Gatis Deksnis

02/03/2015

Capital: Apmaksātais pamatkapitāls 2845 EUR

2845 EUR

16/02/2015

SIA shareholder: Baltic Biomax, Sabiedrība ar ierobežotu atbildību (2845 shares)

Baltic Biomax, Sabiedrība ar ierobežotu atbildību (2845 shares)

27/01/2010

Founding registered

20/01/2010

Company registered

10/01/2010

Founding decision signed